Anxo Pharmaceutical Co., Ltd. (6677) Stock Price & Analysis
6677 Stock Chart & Stats
- Day’s Range
- TWD 20.40 - TWD 21.10
- 52-Week Range
- TWD 15.50 - TWD 25.30
- Previous Close
- TWD 21.60
- Volume
- N/A
- Average Volume (3M)
- 107.09K
- Market Cap
- TWD 1.18B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 334.82M
- Total Debt (Recent Filing)
- TWD 741.47M
- Price to Earnings (P/E)
- ―
- Beta
- 0.43
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 26, 2024
- Dividend Yield
- N/A
6677 FAQ
What was Anxo Pharmaceutical Co., Ltd.’s price range in the past 12 months?
What is Anxo Pharmaceutical Co., Ltd.’s market cap?
When is Anxo Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Is Anxo Pharmaceutical Co., Ltd. overvalued?
Does Anxo Pharmaceutical Co., Ltd. pay dividends?
What is Anxo Pharmaceutical Co., Ltd.’s EPS estimate?
How many shares outstanding does Anxo Pharmaceutical Co., Ltd. have?
Which hedge fund is a major shareholder of Anxo Pharmaceutical Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Anxo Pharmaceutical Co., Ltd.
Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the pharmaceutical sector. This company is actively involved in the research, production, and global distribution of various medicinal products, catering to both healthcare professionals and individual patients, particularly within Taiwan and across international markets. Its comprehensive product catalog features both prescription-only drugs and over-the-counter remedies, addressing a broad spectrum of therapeutic needs. These include cardiovascular health, metabolic disorders, conditions affecting the central nervous system, diabetes management, respiratory ailments, anti-infective treatments, dermatological issues, nephrology, urology, and orthopedics, among others. More specifically, Anxo supplies agents for antidiabetic and dyslipidemic conditions, supports cardiovascular and circulatory systems, offers therapies for the nervous system, addresses hepatological and gastroenterological concerns, provides anti-infective and antiviral agents, and assists with hemodialysis and urinary system treatments. Additionally, their offerings cover respiratory system and antihistamine applications, various analgesics, and other specialized medications, including a range of injectable pharmaceuticals. Established in 2003, the company's main operational base is situated in Taipei, Taiwan.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Linquan Yan
- Employees
- 15
- Website
- www.anxo.com.tw
- Address
- No.206, Nanjing East Road, Taipei, TP, 10489, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 5 | 5 |
| Technical Analysis | 2 | 5 | 3 |
| Moving Averages | 10 | 0 | 2 |
